Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
QuintilesIMS
Chinese Patent Office
Mallinckrodt
Covington
Harvard Business School
Teva
Deloitte
Merck

Generated: May 27, 2018

DrugPatentWatch Database Preview

VALTREX Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Valtrex patents expire, and when can generic versions of Valtrex launch?

Valtrex is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in VALTREX is valacyclovir hydrochloride. There are twenty-three drug master file entries for this compound. Fifty suppliers are listed for this compound. Additional details are available on the valacyclovir hydrochloride profile page.
Drug patent expirations by year for VALTREX
Synonyms for VALTREX
124832-27-5
136489-37-7
2-((2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester monohydrochloride; L-Valine; Valtrex
2-((2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)methoxy)ethyl L-valinate hydrochloride
2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methyl-butanoate
2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methyl-butanoate hydrochloride
2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]ethyl (2S)-2-amino-3-methylbutanoate hydrochloride
256u
256U87 HCl
256U87 hydrochloride
AB0012705
AB1009371
AC-8065
AC1L1TW2
AC1Q3EH7
acyclovir, L-valyl ester
AK163588
AKOS008901386
AKOS015951215
Ambap124832-26-4
AN-8355
API0004558
BB_SC-5094
BC202740
BW 256
BW 256U87
BW-256U87
C07184
C13H20N6O4.HCl
CAS-124832-27-5
CCG-100889
CCG-213402
CHEBI:9919
CHEMBL1201110
CPD000469208
CS-1966
D00398
D05MFA
DSSTox_CID_24210
DSSTox_GSID_44210
DSSTox_RID_80121
DTXSID2044210
FT-0631117
G447S0T1VC
H32V264
HMS1922F20
HY-17425A
KB-62215
KS-1126
L-Valacyclovir Hydrochloride
L-Valine 2-(2-Amino-1,6-dihydro-6-oxo-9H-purin-9-ylmethoxy)ethyl Ester Hydrochloride
L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)ethyl ester, monohydrochloride
L-valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]ethyl ester, monohydrochloride
L-Valine, ester with 9-((2-hydroxyethoxy)methyl)guanine, monohydrochloride
L-valylacyclovir
LS-172602
MFCD01861507
MLS001401440
MolPort-003-666-655
MolPort-046-033-466
NC00139
NCGC00159520-02
NCGC00178638-02
NSC-759101
NSC759101
Pharmakon1600-01505368
s1876
SAM001246749
SCHEMBL40830
SMR000469208
SPECTRUM1505368
SureCN1888797
SureCN5665934
Tox21_111738
Tox21_111738_1
UNII-G447S0T1VC
V0111
Valaciclovir for system suitability, European Pharmacopoeia (EP) Reference Standard
Valaciclovir Hcl
Valaciclovir hydrochloride
Valaciclovir hydrochloride (anhydrous), European Pharmacopoeia (EP) Reference Standard
Valaciclovir hydrochloride (JP17)
Valacyclovir (hydrochloride)
Valacyclovir HCl
Valacyclovir hydrochloride
Valacyclovir hydrochloride (USAN)
Valacyclovir hydrochloride [USAN:USP]
Valacyclovir hydrochloride [USAN]
Valacyclovir hydrochloride, United States Pharmacopeia (USP) Reference Standard
ZCDDBUOENGJMLV-QRPNPIFTSA-N

US Patents and Regulatory Information for VALTREX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-002 Jun 23, 1995 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-001 Jun 23, 1995 AB RX Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for VALTREX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-001 Jun 23, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-002 Jun 23, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-002 Jun 23, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline VALTREX valacyclovir hydrochloride TABLET;ORAL 020487-001 Jun 23, 1995 ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cerilliant
Medtronic
Chubb
Fuji
Mallinckrodt
AstraZeneca
McKinsey
UBS
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.